{"id":74195,"date":"2018-11-14T01:00:00","date_gmt":"2018-12-07T05:23:45","guid":{"rendered":"http:\/\/www.05921.net\/index.php\/2018\/12\/07\/2bf29c543b\/"},"modified":"2018-12-07T13:23:46","modified_gmt":"2018-12-07T05:23:46","slug":"2bf29c543b","status":"publish","type":"post","link":"https:\/\/www.05921.net\/index.php\/74195\/","title":{"rendered":"Module\u2014\u20141.3.1 \u4ea7\u54c1\u7684\u7279\u6027\u6458\u8981"},"content":{"rendered":"
\n

\u70b9\u51fb\u4e0a\u65b9\u7684  \u25b2 \u6dfb\u52a0\u5173\u6ce8<\/span><\/p>\n


<\/span><\/p>\n

SUMMARY OF PRODUCT CHARACTERISTICS<\/span>\uff08\u4ea7\u54c1\u7684\u7279\u6027\u6458\u8981<\/span>\uff09<\/span><\/h1>\n

 <\/span><\/p>\n

Ps<\/span><\/em><\/strong>\uff1a\u6b64\u90e8\u5206\u4fe1\u606f\u4e0e\u836f\u54c1\u7684\u8bf4\u660e\u4e66\u7c7b\u4f3c\uff0c\u5185\u5bb9\u4e0e\u8bf4\u660e\u4e66\u76f8\u6bd4\u8f83\u5e94\u66f4\u52a0\u8be6\u7ec6\u3002(SMPC\u4f9b\u533b\u751f\u53ca\u7814\u7a76\u8005\u9605\u8bfb\uff0c\u8bf4\u660e\u4e66\u5219\u4f9b\u60a3\u8005\u4f7f\u7528\u9605\u8bfb)<\/span><\/em><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

1.      NAME OF THE MEDICINAL PRODUCT<\/span><\/strong>\uff08\u836f\u7269\u540d\u79f0\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

2.      QUALITATIVE AND QUANTITATIVE COMPOSITION<\/span><\/strong>\uff08\u836f\u7269\u7ec4\u6210\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

3.      PHARMACEUTICAL FORM<\/span><\/strong>\uff08\u5242\u578b\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span> <\/span><\/span><\/p>\n

4.      CLINICAL PARTICULARS<\/span><\/strong>\uff08\u4e34\u5e8a\u7814\u7a76\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

4.1<\/span><\/strong>    Therapeuticindications<\/strong><\/span>\uff08\u9002\u5e94\u75c7\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

4.2      Posology andmethod of administration<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

Posology<\/span><\/p>\n

 <\/span><\/p>\n

Paediatricpopulation<\/span><\/p>\n

 <\/span><\/p>\n

<The<safety> <and> <efficacy> of {X} in children aged {x to y}<months> <years> {or any other relevant subsets e.g. weight,pubertal age, gender} <has> <have> not <yet> beenestablished.><\/span><\/p>\n

 <\/span><\/p>\n

<Nodata are available.> <Currently available data are described in Section<4.8> <5.1> <5.2> but no recommendation on a posology can bemade.><\/span><\/p>\n

 <\/span><\/p>\n

<{X}should not be used in children aged {x to y} <years> <months> {orany other relevant subsets e.g. weight, pubertal age, gender} because of<safety> <efficacy> concern(s).><\/span><\/p>\n

 <\/span><\/p>\n

<Thereis no relevant use of {X} <in the paediatric population> <in childrenaged {x to y} <years>, <months> {or any other relevant subsets e.g.weight, pubertal age, gender} <in the indication…> <\/span><\/p>\n

 <\/span><\/p>\n

<{X}is contraindicated in children aged {x to y} <years> <months> {orany other relevant subsets e.g. weight, pubertal age, gender} <in theindication…> (see Section 4.3).><\/span><\/p>\n

 <\/span><\/p>\n

Methodof administration<\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

4.3      Contraindications<\/span><\/strong>\uff08\u7981\u5fcc\u75c7\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<Hypersensitivityto the active substance(s) or to any of the excipients <or {name of theresidue(s)}>.><\/span><\/p>\n

 <\/span><\/p>\n

4.4    Special warnings and precautions for use<\/span><\/strong>\uff08\u6ce8\u610f\u4e8b\u9879\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

4.5    Interaction with other medicinal products and other forms ofinteraction<\/span><\/strong>\uff08\u836f\u7269\u76f8\u4e92\u4f5c\u7528\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<No interaction studies have been performed.><\/span><\/p>\n

 <\/span><\/p>\n

<Interaction studies have only been performed inadults.><\/span><\/p>\n

 <\/span><\/p>\n

4.6    Pregnancy and lactation<\/span><\/strong>\uff08\u598a\u5a20\u548c\u54fa\u4e73\u671f\u6ce8\u610f\u4e8b\u9879\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/em><\/span><\/p>\n

[See prequalification guidance<\/span><\/em>: <\/span><\/em>Section Guidance for Part 4 \u2014 Summary ofProduct Characteristics (SmPC) \u2014 of a WHO Public Assessment Report (WHOPAR).<\/span>]<\/span><\/em><\/span><\/p>\n

 <\/span><\/em><\/span><\/p>\n

<Women of childbearing potential><\/span><\/p>\n

 <\/span><\/p>\n

<Contraception in males and females><\/span><\/p>\n

 <\/span><\/p>\n

<Pregnancy><\/span><\/p>\n

 <\/span><\/p>\n

<Breastfeeding><\/span><\/p>\n

 <\/span><\/p>\n

<Fertility><\/span><\/p>\n


<\/span><\/strong><\/span><\/p>\n

4.7    Effects on ability to drive and use machines<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<{Inventedname} has <no <or negligible> influence> <minor influence>,<moderate influence> <major influence> on the ability to drive anduse machines.><\/span><\/p>\n

 <\/span><\/p>\n

<Nostudies on the effects on the ability to drive and use machines have beenperformed.><\/span><\/p>\n

 <\/span><\/p>\n

<Notrelevant.><\/span><\/p>\n

 <\/span><\/p>\n

4.8     <\/span><\/span><\/strong>Undesirableeffects<\/span><\/strong>\uff08\u4e0d\u826f\u53cd\u5e94\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/em><\/span><\/p>\n

[See prequalificationguidance<\/span><\/em>: <\/span><\/em>Section Guidance for Part 4 \u2014 Summary ofProduct Characteristics (SmPC) \u2014 of a WHO Public Assessment Report (WHOPAR).<\/span>]<\/span><\/em><\/span><\/p>\n


<\/em><\/span><\/p>\n

<Paediatric population><\/em><\/span><\/p>\n


<\/span><\/strong><\/span><\/p>\n

4.9    Overdose<\/span><\/strong>\uff08\u836f\u7269\u8fc7\u91cf\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<No caseof overdose has been reported.><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

5. PHARMACOLOGICAL PROPERTIES<\/span><\/strong>\uff08\u836f\u7406\u4f5c\u7528\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span> <\/span><\/strong><\/span><\/p>\n

5.1Pharmacodynamic properties<\/span><\/strong>\uff08\u836f\u6548\u5b66\u4fe1\u606f\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

5.2 Pharmacokinetic particulars<\/span><\/strong>\uff08\u836f\u4ee3\u52a8\u529b\u5b66\u4fe1\u606f\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

5.3Preclinical safety data<\/span><\/strong>\uff08\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u4fe1\u606f\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

6.      PHARMACEUTICAL PARTICULARS<\/span><\/strong>\uff08\u836f\u54c1\u8be6\u60c5\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

6.1    List of excipients<\/span><\/strong>\uff08\u8f85\u6599\u6e05\u5355\uff09<\/span><\/strong><\/span><\/p>\n

  <\/span><\/p>\n

6.2    Incompatibilities<\/span><\/strong>\uff08\u914d\u4f0d\u7981\u5fcc\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<Not applicable.><\/span><\/p>\n

 <\/span><\/p>\n

<In the absence of compatibility studies, this medicinalproduct must not be mixed with other medicinal products.><\/span><\/p>\n

 <\/span><\/p>\n

<This medicinal product must not be mixed with othermedicinal products except those mentioned in Section 6.6.><\/span><\/p>\n

 <\/span><\/p>\n

6.3    Shelf life<\/span><\/strong>\uff08\u8d27\u67b6\u671f\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<…> <6 months><…> <1 year> <18 months> <2 years> <30 months><3 years> <…><\/span><\/p>\n

 <\/span><\/p>\n

6.4    Special precautions for storage<\/span><\/strong>\uff08\u50a8\u5b58\u6ce8\u610f\u4e8b\u9879\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<For storage conditions of the <reconstituted><diluted> medicinal product, see Section 6.3.><\/span><\/p>\n


<\/span><\/strong><\/span><\/p>\n

6.5     <\/span><\/span><\/strong>Natureand composition of immediate packaging<and special equipment for use,administration or implantation><\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

6.6    Specialprecautions for the disposal of unused veterinary medicinal product or wastematerials derived from the use of such products<\/span><\/strong><\/span><\/p>\n

 <\/span><\/p>\n

<No special requirements.><\/span><\/p>\n

 <\/span><\/p>\n

<Any unused product or waste material should be disposedof in accordance with local requirements.><\/span><\/p>\n


<\/span><\/strong><\/span><\/p>\n

7       <\/span><\/strong>APPLICANT\/SUPPLIER<\/span><\/strong>\uff08\u4f9b\u5e94\u5546\uff09<\/span><\/strong><\/span><\/p>\n

{Name and address}<\/span><\/p>\n

<{tel}><\/span><\/p>\n

<{fax}><\/span><\/p>\n

<{email}><\/span><\/p>\n

 <\/span><\/p>\n

8.      PREQUALIFICATIONREFERENCE NUMBER<\/span><\/strong><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

9.      DATE OF FIRST AUTHORISATION\/RENEWAL OF THEAUTHORISATION<\/span><\/strong>\uff08\u9996\u6b21\u83b7\u6279\u65e5\u671f\u53ca\u518d\u6ce8\u518c\u65e5\u671f\uff09<\/span><\/strong><\/span><\/p>\n

 <\/span><\/strong><\/span><\/p>\n

{MM\/YYYY}<\/span><\/p>\n


<\/span><\/strong><\/span><\/p>\n

10.    DATEOF REVISION OF THE TEXT<\/span><\/strong>\uff08\u4fee\u6539\u65e5\u671f\uff09<\/span><\/strong><\/span><\/p>\n

<{DD\/MM\/YYYY}> <{DD month YYYY}><\/span><\/p>\n


<\/p>\n

\n


<\/span><\/strong><\/p>\n

Module 1:Administrative Information and Prescribing Information<\/span><\/strong><\/p>\n


<\/span><\/span><\/p>\n

1.1 \u76ee\u5f55<\/span>
1.2 \u7533\u8bf7\u8868<\/span><\/span><\/p>\n

1.3 \u4ea7\u54c1\u4fe1\u606f\u76f8\u5173\u8d44\u6599<\/span><\/p>\n

1.3.1 \u4ea7\u54c1\u7684\u7279\u6027\u6458\u8981\uff08SMPC\uff09<\/span><\/p>\n

1.3.2 \u8bf4\u660e\u4e66<\/span><\/a><\/p>\n

1.3.2.1 \u7814\u7a76\u836f\u7269\u8bf4\u660e\u4e66\uff08IND\uff09<\/span><\/a><\/p>\n

1.3.2.2 \u4e0a\u5e02\u836f\u7269\u8bf4\u660e\u4e66\uff08NDA\uff09<\/span><\/a><\/p>\n

1.3.3 \u5305\u88c5\u6807\u7b7e<\/span><\/p>\n

1.3.3.1 \u7814\u7a76\u836f\u7269\u5305\u88c5\u6807\u7b7e\uff08IND\uff09<\/span><\/p>\n

1.3.3.2\u4e0a\u5e02\u836f\u7269\u5305\u88c5\u6807\u7b7e\uff08NDA\uff09<\/span><\/p>\n

1.3.4 \u4ea7\u54c1\u8d28\u91cf\u6807\u51c6\u548c\u751f\u4ea7\u5de5\u827a\/\u5236\u9020\u4e0e\u68c0\u5b9a\u89c4\u7a0b<\/span><\/p>\n

1.3.5 \u4e34\u5e8a\u8bd5\u9a8c\u76f8\u5173\u8d44\u6599<\/span><\/p>\n

1.3.5.1 \u4e34\u5e8a\u8bd5\u9a8c\u76f8\u5173\u6750\u6599<\/span><\/p>\n

1.3.5.2 \u77e5\u60c5\u540c\u610f\u4e66<\/span><\/p>\n

1.3.5.3 \u7814\u7a76\u8005\u624b\u518c<\/span><\/p>\n

1.3.6 \u4ea7\u54c1\u76f8\u5173\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.3.6.1 \u836f\u54c1\u901a\u7528\u540d\u79f0\u7684\u547d\u540d\u8bc1\u660e\u6027\u6587\u4ef6\uff08\u5982\u4f7f\u7528\uff09<\/span><\/p>\n

1.3.6.2 \u4e13\u5229\u4fe1\u606f\u53ca\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.3.6.3 \u7279\u6b8a\u836f\u54c1\u7814\u5236\u7acb\u9879\u6279\u51c6\u6587\u4ef6\uff08\u5982\u4f7f\u7528\uff09<\/span><\/p>\n

1.3.6.4 \u5546\u6807\u4fe1\u606f\u53ca\u8bc1\u660e\u6587\u4ef6\uff08\u5982\u4f7f\u7528\uff09<\/span><\/p>\n

1.3.6.5 \u53c2\u6bd4\u5236\u5242\u53ca\u53c2\u7167\u836f\u5408\u6cd5\u6765\u6e90\u6587\u4ef6\uff08\u5982\u4f7f\u7528\uff09<\/span><\/p>\n

1.3.6.6 \u836f\u7269\u4e34\u5e8a\u8bd5\u9a8c\u76f8\u5173\u8bc1\u660e\u6587\u4ef6\uff08NDA\u7533\u8bf7\uff09<\/span><\/p>\n

1.3.6.7 \u539f\u6599\u836f\u3001\u836f\u7528\u8f85\u6599\u53ca\u836f\u7528\u836f\u5305\u6750\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.3.6.7.1 \u5408\u6cd5\u6765\u6e90\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.3.6.7.2 \u6388\u6743\u4f7f\u7528\u4e66\u53ca\u767b\u8bb0\u53f7<\/span><\/p>\n

1.3.6.8 \u539f\u6599\u836f\u3001\u539f\u6750\u6599\u65e0\u52a8\u7269\u6765\u6e90\u8bc1\u660e<\/span><\/p>\n

1.3.6.9 \u59d4\u6258\u7814\u7a76\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.3.6.10 \u836f\u5668\u7ec4\u5408\u76f8\u5173\u4ea7\u54c1\u8bc1\u660e\u6027\u6587\u4ef6\uff08\u5982\u4f7f\u7528\uff09<\/span><\/p>\n

1.3.6.11 \u5141\u8bb8\u836f\u54c1\u4e0a\u5e02\u9500\u552e\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.3.6.12 \u5141\u8bb8\u836f\u54c1\u53d8\u66f4\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.3.6.13 \u5176\u5b83\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.4 \u7533\u8bf7\u72b6\u6001
<\/span><\/p>\n

1.4.1 \u65e2\u5f80\u6279\u51c6\u60c5\u51b5<\/span><\/p>\n

1.4.2 \u7533\u8bf7\u64a4\u56de\u4e34\u5e8a\u836f\u7269\u8bd5\u9a8c\u7533\u8bf7<\/span><\/p>\n

1.4.3 \u7533\u8bf7\u7b54\u590d\u548c\u6062\u590d\u4e34\u5e8a\u8bd5\u9a8c<\/span><\/p>\n

1.4.4 \u7533\u8bf7\u64a4\u56de\u672a\u7ecf\u6279\u51c6\u7684\u4e0a\u5e02\u7533\u8bf7\u3001\u4eff\u5236\u836f\u7533\u8bf7\u6216\u8865\u5145\u7533\u8bf7<\/span><\/p>\n

1.4.5 \u7533\u8bf7\u64a4\u56de\u4e0a\u5e02\u836f\u7269<\/span><\/p>\n

1.4.6 \u7533\u8bf7\u64a4\u56de\u6279\u51c6\u7684\u7533\u8bf7\u6216\u6ce8\u9500\u4e0a\u5e02\u8bb8\u53ef\u6279\u51c6\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.5 \u52a0\u5feb\u5ba1\u8bc4\u5ba1\u6279\u901a\u9053\u7533\u8bf7<\/span><\/p>\n

1.5.1 \u52a0\u5feb\u5ba1\u8bc4\u5ba1\u6279\u901a\u9053\u8ba4\u5b9a\u7533\u8bf7<\/span><\/p>\n

1.5.2 \u52a0\u5feb\u5ba1\u8bc4\u5ba1\u6279\u901a\u9053\u8ba4\u5b9a\u64a4\u56de\u7533\u8bf7<\/span><\/p>\n

1.5.3 \u6eda\u52a8\u5ba1\u8bc4\u7533\u8bf7<\/span><\/p>\n

1.5.4 \u6709\u5173\u5feb\u901f\u8ddf\u8e2a\u3001\u6eda\u52a8\u5ba1\u8bc4\u7684\u6c9f\u901a\u4ea4\u6d41\u4f1a\u4fe1\u51fd\u53ca\u4f1a\u8bae\u7eaa\u8981<\/span><\/p>\n

1.6 \u6c9f\u901a\u4ea4\u6d41\u4f1a<\/span><\/p>\n

1.6.1 \u4f1a\u8bae\u7533\u8bf7<\/span><\/p>\n

1.6.2 \u4f1a\u8bae\u5317\u4eac\u8d44\u6599<\/span><\/p>\n

1.6.3 \u4f1a\u8bae\u76f8\u5173\u4fe1\u51fd\u53ca\u4f1a\u8bae\u7eaa\u8981<\/span><\/p>\n

1.7 \u4e34\u5e8a\u8bd5\u9a8c\u8fc7\u7a0b\u7ba1\u7406\u4fe1\u606f<\/span><\/p>\n

1.7.1 \u65b0\u65b9\u6848\u63d0\u4ea4<\/span><\/p>\n

1.7.2 \u4e34\u5e8a\u8bd5\u9a8c\u671f\u95f4\u76f8\u5173\u53d8\u66f4\uff08\u4e00\u822c\u53d8\u66f4\u53ca\u91cd\u5927\u53d8\u66f4\uff09<\/span><\/p>\n

1.7.3 \u4fe1\u606f\u66f4\u65b0\uff08\u836f\u5b66\u3001\u836f\u7406\u6bd2\u7406\u3001\u4e34\u5e8a\u3001\u591a\u5b66\u79d1\u7b49\uff09<\/span><\/p>\n

1.8 \u98ce\u9669\u7ba1\u7406\u8ba1\u5212<\/span><\/p>\n

1.8.1 \u4e34\u5e8a\u8bd5\u9a8c\u671f\u95f4\u7684\u98ce\u9669\u7ba1\u7406<\/span><\/p>\n

1.8.1.1 \u5b9a\u671f\u62a5\u544a<\/span><\/p>\n

1.8.1.2 \u53ef\u7591\u975e\u9884\u671f\u4e25\u91cd\u4e0d\u826f\u53cd\u5e94\u62a5\u544a<\/span><\/p>\n

1.8.2 \u98ce\u9669\u8bc4\u4f30\u53ca\u6700\u5c0f\u5316\u7b56\u7565\uff08REMS\uff09<\/span><\/p>\n

1.8.2.1 \u98ce\u9669\u8bc4\u4f30\u53ca\u6700\u5c0f\u5316\u7b56\u7565\u7ec8\u7248<\/span><\/p>\n

1.8.2.2 REMS\u8bc4\u4f30\u53ca\u8bc4\u4f30\u65b9\u6cd5<\/span><\/p>\n

1.8.2.3 REMS\u8d77\u8349\u53ca\u4fee\u8ba2\u5386\u53f2\u8bb0\u5f55\u53ca\u4f9d\u636e<\/span><\/p>\n

1.9 \u4e0a\u5e02\u540e\u7814\u7a76<\/span><\/p>\n

1.9.1 \u4e0a\u5e02\u540e\u7814\u7a76\u627f\u8bfa\u76f8\u5173\u8d44\u6599<\/span><\/p>\n

1.9.2 \u4e0a\u5e02\u540e\u7814\u7a76\u8981\u6c42\u76f8\u5173\u6279\u4ef6<\/span><\/p>\n

1.10 \u4e0a\u5e02\u540e\u53d8\u66f4<\/span><\/p>\n

1.10.1 \u4e0a\u5e02\u540e\u836f\u5b66\u53d8\u66f4<\/span><\/p>\n

1.10.2 \u4e0a\u5e02\u540e\u8bf4\u660e\u4e66\u4fe1\u606f\u53d8\u66f4\uff08\u9664\u9002\u5e94\u75c7\u3001\u7528\u6cd5\u7528\u91cf\u53ca\u7ed9\u836f\u9014\u5f84\u53d8\u66f4\uff09<\/span><\/p>\n

1.10.3 \u4e0a\u5e02\u8bb8\u53ef\u6240\u6709\u4eba\u53d8\u66f4<\/span><\/p>\n

1.10.4 \u4e0a\u5e02\u540e\u5176\u5b83\u53d8\u66f4<\/span><\/p>\n

1.11 \u7533\u8bf7\u4eba\/\u4e0a\u5e02\u8bb8\u53ef\u4eba\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.11.1 \u7533\u8bf7\u4eba\u8d44\u8d28\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.11.1.1 \u7533\u8bf7\u4eba\u673a\u6784\u5408\u6cd5\u8bc1\u660e\u6587\u4ef6\uff08\u8425\u4e1a\u6267\u7167\u3001\u836f\u54c1\u751f\u4ea7\u8bb8\u53ef\u8bc1\u53ca\u53d8\u66f4\u8bb0\u5f55\u9875\u3001\u836f\u54c1\u751f\u4ea7\u8d28\u91cf\u7ba1\u7406\u89c4\u8303\u8ba4\u8bc1\uff09<\/span><\/p>\n

1.11.1.2 \u5883\u5916\u836f\u54c1\u751f\u4ea7\u4f01\u4e1a\u7b26\u5408\u836f\u54c1\u751f\u4ea7\u8d28\u91cf\u7ba1\u7406\u89c4\u8303\u7684\u8bc1\u660e\u6027\u6587\u4ef6<\/span><\/p>\n

1.11.1.3 \u836f\u54c1\u6ce8\u518c\u4ee3\u7406\u673a\u6784\u8bc1\u660e\u6587\u4ef6<\/span><\/p>\n

1.11.2 \u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u8bc1\u660e\u6587\u4ef6\uff08\u5982\u9002\u7528\uff09<\/span><\/p>\n

1.12 \u5c0f\u5fae\u4f01\u4e1a\u8bc1\u660e\u6587\u4ef6\uff08\u5982\u7b26\u5408\u5c0f\u5fae\u4f01\u4e1a\u884c\u653f\u4e8b\u4e1a\u6027\u6536\u8d39\u4f18\u60e0\u653f\u7b56\uff0c\u53ef\u63d0\u4ea4\u5c0f\u5fae\u4f01\u4e1a\u884c\u653f\u4e8b\u4e1a\u6027\u6536\u8d39\u4f18\u60e0\u7533\u8bf7\u8868\u53ca\u8bc1\u660e\u6027\u6587\u4ef6<\/span>\uff09<\/span><\/p>\n


<\/p>\n

\n
\n
\n
\n
\n

Module 1\u2014<\/span><\/strong><\/span>\u20141.3.1 \u4ea7\u54c1\u7684\u7279\u6027\u6458\u8981<\/span><\/strong><\/span><\/span><\/span><\/strong><\/span><\/p>\n

https:\/\/pan.baidu.com\/s\/1I0DnnH4lrUrtbOAK-tNvyg<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n

\u5b66\u5982\u9006\u6c34\u884c\u821f\uff0c\u4e0d\u8fdb\u5219\u9000\uff1b<\/span><\/p>\n

\u5fc3\u4f3c\u5e73\u539f\u8d70\u9a6c\uff0c\u6613\u653e\u96be\u6536\u3002<\/span><\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
<\/section>\n<\/section>\n<\/section>\n
\n
\n
\n

<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n


<\/p>\n

\"Module\u2014\u20141.3.1<\/p>\n


<\/p>\n


<\/p>\n

\n
\n
\n
\n
\n

<\/span><\/p>\n<\/section>\n

\n

\u6bcf\u65e5\u66f4\u65b0 \u6b22\u8fce\u8ba2\u9605+<\/span><\/p>\n

\n


<\/p>\n

\n<\/section>\n


<\/p>\n

\u533b\u836f\u5927\u6570\u636e|\u884c\u4e1a\u52a8\u6001|\u653f\u7b56\u89e3\u8bfb<\/span><\/p>\n


<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section><\/div>\n","protected":false},"excerpt":{"rendered":"

\u70b9\u51fb\u4e0a\u65b9\u7684  \u25b2 \u6dfb\u52a0\u5173\u6ce8 SUMMARY OF PRODUCT CHARACT […]<\/p>\n","protected":false},"author":1,"featured_media":74196,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/74195"}],"collection":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/comments?post=74195"}],"version-history":[{"count":1,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/74195\/revisions"}],"predecessor-version":[{"id":74198,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/posts\/74195\/revisions\/74198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media\/74196"}],"wp:attachment":[{"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/media?parent=74195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/categories?post=74195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.05921.net\/index.php\/wp-json\/wp\/v2\/tags?post=74195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}